Church & Dwight Co., Inc. (NYSE:CHD) CEO Matthew Farrell Sells 300,000 Shares

Church & Dwight Co., Inc. (NYSE:CHD - Get Free Report) CEO Matthew Farrell sold 300,000 shares of the business's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $103.84, for a total value of $31,152,000.00. Following the completion of the sale, the chief executive officer now owns 112,719 shares of the company's stock, valued at $11,704,740.96. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Matthew Farrell also recently made the following trade(s):

• On Monday, November 4th, Matthew Farrell sold 165,823 shares of Church & Dwight stock. The stock was sold at an average price of $103.03, for a total transaction of $17,084,743.69.

Church & Dwight Trading Up 0.7 %

Shares of NYSE:CHD traded up $0.70 during trading on Thursday, reaching $103.91. The stock had a trading volume of 1,442,387 shares, compared to its average volume of 1,386,386. Church & Dwight Co., Inc. has a 52 week low of $88.37 and a 52 week high of $110.31. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.09 and a current ratio of 1.62. The firm's fifty day moving average is $103.01 and its 200 day moving average is $104.02. The stock has a market cap of $25.46 billion, a price-to-earnings ratio of 46.60, a P/E/G ratio of 3.78 and a beta of 0.55.

Church & Dwight (NYSE:CHD - Get Free Report) last issued its earnings results on Friday, November 1st. The company reported $0.79 earnings per share for the quarter, topping analysts' consensus estimates of $0.68 by $0.11. The business had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.50 billion. Church & Dwight had a return on equity of 19.90% and a net margin of 9.08%. The firm's revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.74 earnings per share. As a group, equities analysts forecast that Church & Dwight Co., Inc. will post 3.45 EPS for the current fiscal year.

Church & Dwight Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Friday, November 15th will be given a dividend of $0.2838 per share. The ex-dividend date is Friday, November 15th. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.09%. Church & Dwight's dividend payout ratio (DPR) is presently 50.67%.

Institutional Trading of Church & Dwight

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Quest Partners LLC bought a new stake in shares of Church & Dwight during the third quarter worth about $253,000. Swiss National Bank increased its position in shares of Church & Dwight by 0.5% during the third quarter. Swiss National Bank now owns 725,800 shares of the company's stock valued at $76,006,000 after acquiring an additional 3,600 shares during the last quarter. S&CO Inc. lifted its holdings in Church & Dwight by 0.7% during the third quarter. S&CO Inc. now owns 652,621 shares of the company's stock worth $68,342,000 after acquiring an additional 4,705 shares during the period. Thrivent Financial for Lutherans boosted its position in Church & Dwight by 5.7% in the third quarter. Thrivent Financial for Lutherans now owns 30,266 shares of the company's stock worth $3,170,000 after purchasing an additional 1,638 shares during the last quarter. Finally, Natixis Advisors LLC grew its stake in Church & Dwight by 2.2% in the 3rd quarter. Natixis Advisors LLC now owns 164,329 shares of the company's stock valued at $17,209,000 after purchasing an additional 3,573 shares during the period. 86.60% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CHD shares. Evercore ISI cut their target price on Church & Dwight from $110.00 to $101.00 and set an "in-line" rating for the company in a research report on Monday, August 5th. TD Cowen upped their price objective on Church & Dwight from $114.00 to $117.00 and gave the stock a "buy" rating in a research report on Monday. Truist Financial reduced their price objective on Church & Dwight from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, August 5th. Stifel Nicolaus dropped their target price on shares of Church & Dwight from $107.00 to $105.00 and set a "hold" rating for the company in a report on Monday, August 5th. Finally, Wells Fargo & Company raised their price target on shares of Church & Dwight from $113.00 to $115.00 and gave the company an "overweight" rating in a research note on Monday. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Church & Dwight currently has a consensus rating of "Hold" and a consensus target price of $108.05.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.